Liraglutide: Liraglutide is in a new class of drugs called GLP-1 analogues that lower blood glucose levels. Liraglutide will stimulate insulin secretion only when blood glucose levels are higher than normal, which will decrease the risk of hypoglycemia. Taking medication is not a guarantee that blood sugar levels will be kept at acceptable levels; diabetics need to test their blood sugar with either a blood glucose meter or blood sugar monitor.

Liraglutide Provides Significantly Better Glucose Control Than Insulin Glargine In Phase 3 Study
Liraglutide Provides Significantly Better Glucose Control Than Insulin Glargine In Phase 3 Study Article Date: 22 Jun 2007 - 0:00 PDT Medicalnewstoday.com Novo Nordisk today announced clinical
Liraglutide – Next-Generation Antidiabetic Medication
Liraglutide – Next-Generation Antidiabetic Medication drugdevelopment-technology.com Drug (Brand/Generic) Liraglutide Company/Licensee Novo Nordisk Therapy Class GLP-1 analogue Product D
New Diabetes Drug Liraglutide Works
New Diabetes Drug Liraglutide Works September 24, 2008 By Daniel J. DeNoon WebMD Liraglutide, a new drug in the same class as Byetta, cuts blood sugar and lowers weight in a yearlong study of